Nexgel (NXGL) Cash & Equivalents Growth (3y) (2022 - 2025)
Nexgel (NXGL) Cash & Equivalents Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -2.17% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -25.69% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 93.87% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -16.21% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.45% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 8.39% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 6.48% |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | -1.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.32% |
| Sep 30, 2025 | -13.05% |
| Jun 30, 2025 | -45.26% |
| Mar 31, 2025 | -51.50% |
| Dec 31, 2024 | -48.66% |
| Sep 30, 2024 | -5.50% |
| Jun 30, 2024 | 40.92% |
| Mar 31, 2024 | 31.25% |
| Dec 31, 2023 | 338.60% |
| Sep 30, 2023 | 175.98% |
| Jun 30, 2023 | 151.15% |
| Mar 31, 2023 | 52.94% |
| Dec 31, 2022 | 61.58% |
| Sep 30, 2022 | 153.11% |
| Jun 30, 2022 | 187.50% |